WE
CVS icon

Wealth Effects’s CVS Health CVS Stock Holding History

Wealth Effects’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$421K Buy
5,856
+96
+2% +$7.39K 0.15% 125
2025
Q4 		$457K Sell
5,760
-199
-3% -$15.7K 0.14% 118
2025
Q3 		$449K Buy
5,959
+1,545
+35% +$106K 0.14% 120
2025
Q2 		$304K Sell
4,414
-573
-11% -$37.6K 0.11% 146
2025
Q1 		$338K Sell
4,987
-1,179
-19% -$70.6K 0.14% 128
2024
Q4 		$277K Sell
6,166
-924
-13% -$51.8K 0.1% 167
2024
Q3 		$446K Sell
7,090
-356
-5% -$20.8K 0.16% 117
2024
Q2 		$440K Sell
7,446
-10,498
-59% -$657K 0.16% 116
2024
Q1 		$1.43M Sell
17,944
-608
-3% -$46.4K 0.53% 42
2023
Q4 		$1.46M Sell
18,552
-325
-2% -$23.1K 0.55% 39
2023
Q3 		$1.32M Sell
18,877
-275
-1% -$19.5K 0.65% 33
2023
Q2 		$1.32M Buy
19,152
+410
+2% +$29.2K 0.58% 39
2023
Q1 		$1.39M Buy
18,742
+1,235
+7% +$104K 0.71% 34
2022
Q4 		$1.63M Sell
17,507
-3,320
-16% -$320K 0.93% 23
2022
Q3 		$1.99M Sell
20,827
-60
-0.3% -$5.94K 1.21% 16
2022
Q2 		$1.94M Buy
20,887
+101
+0.5% +$9.86K 1.16% 18
2022
Q1 		$2.1M Sell
20,786
-305
-1% -$32K 0.98% 20
2021
Q4 		$2.18M Buy
+21,091
New +$1.95M 0.9% 20

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wealth Effects's CVS Position: Q1 2026 in Review

Wealth Effects increased its CVS Health (CVS) stake by 1.7% in Q1 2026, buying an estimated $7.39K and bringing the position to 5,856 shares worth $421K. The position accounts for 0.15% of the portfolio, ranked #125.

Wealth Effects first reported a position in CVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.18M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Wealth Effects held 5,856 shares of CVS Health worth $421K as of Q1 2026.
  • Wealth Effects bought 96 CVS Health shares in Q1 2026, an estimated $7.39K.
  • CVS Health made up 0.15% of Wealth Effects's portfolio in Q1 2026, its #125 holding.
  • Wealth Effects first reported a position in CVS Health in Q4 2021 and has held it in 18 quarters since.
  • Wealth Effects's CVS Health position peaked at $2.18M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.